Ginkgo Bioworks is a synthetic biology company that designs custom organisms for clients across healthcare, industrial biotechnology, and other sectors. Ginkgo Bioworks leverages advanced software and hardware automation to scale the engineering of organisms, making biology easier to engineer for commercial applications.
Their core offering centers on building and programming organisms—such as microbes—that can produce valuable chemicals, materials, or therapeutics. Ginkgo’s foundries are highly automated labs where organism engineers use data-driven methods to design, test, and optimize biological processes, replacing traditional chemical or mechanical methods with biological solutions.
By combining automation, software, and expertise in synthetic biology, Ginkgo aims to enable customers to harness biology for applications ranging from pharmaceuticals to sustainable materials and specialty chemicals.
What technology enables Ginkgo Bioworks?
Ginkgo Bioworks’ technological edge comes from its integrated foundries—facilities equipped with robotics, high-throughput screening, and custom software tools. These foundries allow for rapid iteration in designing and testing biological systems. The company’s engineers use large datasets and bioinformatics to learn from nature and program organisms for specific, commercial purposes. This approach enables scalable, repeatable organism engineering, reducing the time and cost associated with developing new biological products.
Who are Ginkgo Bioworks’ customers and partners?
Ginkgo primarily serves businesses in the healthcare, diagnostics, agriculture, food, and industrial bio sectors. Customers range from pharmaceutical companies seeking to develop new therapeutics to manufacturers looking for sustainable materials or specialty chemicals produced via engineered organisms. Ginkgo also partners with academic institutions and industry leaders to advance synthetic biology research and commercialization.
Who are Ginkgo Bioworks’ competitors?
Ginkgo operates in the synthetic biology and bioengineering space—a rapidly growing field that blends biology with engineering and data science. Key organizations and entities in this landscape include:
- Engineering Biology Research Consortium (EBRC): A leading resource and network for synthetic biology research and standards.
- MIT Department of Biological Engineering: Renowned for advancing research in synthetic biology.
- University of Illinois Urbana-Champaign Bioengineering: Active in synthetic biology and organism engineering research.
- Northwestern University, McCormick School of Engineering: Focused on biotechnology and bioengineering areas, including synthetic biology.
- Berkeley Bioengineering: A pioneer in synthetic biology innovation.
- SCIEPublish Synthetic Biology and Engineering Journal: Publishes research and developments in synthetic biology and engineering.
While some of these are research institutions and consortiums, the broader competitive landscape also includes other commercial synthetic biology companies and platform providers developing tools for organism design and bio-based manufacturing.
Use PromptLoop to Uncover Company Data
Looking for more company insights like this? PromptLoop helps you go deeper, providing unique data points and analysis on companies like Ginkgo Bioworks and many others. Automate your research and find the information that matters most. Discover how PromptLoop can accelerate your market intelligence. Get A Free Demo to learn more.